Yesterday, a Director at Illumina (NASDAQ: ILMN), Jay Flatley, sold shares of ILMN for $391.3K.
Following Jay Flatley’s last ILMN Sell transaction on August 30, 2017, the stock climbed by 69.1%.
See today’s analyst top recommended stocks >>
Based on Illumina’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $782 million and quarterly net profit of $208 million. In comparison, last year the company earned revenue of $598 million and had a net profit of $366 million. ILMN’s market cap is $39.52B and the company has a P/E ratio of 69.98. Currently, Illumina has an average volume of 564.2K.
Three different firms, including First Analysis and Janney Montgomery, currently also have a Sell rating on the stock. Based on 5 analyst ratings, the analyst consensus is Strong Buy with an average price target of $278.25, reflecting a -3.4% downside.
Jay Flatley’s trades have generated a -11.0% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Illumina, Inc. engages in the development and manufacture of integrated systems for the analysis of genetic variation and function. It operates through the Core Illumina and Consolidated Variable Interest Entity segments (VIE).
